These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15282415)

  • 1. Rotastenting for "complex lesions": benefit unlikely with bare metal stents.
    Ramsdale D; Palmer N
    J Invasive Cardiol; 2004 Aug; 16(8):410. PubMed ID: 15282415
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
    Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rotational atherectomy of a lesion in which stent expansion was limited by severe calcification].
    Fournier JA; Florián F; Ballesteros SM
    Rev Esp Cardiol; 2005 Jul; 58(7):879-80. PubMed ID: 16022823
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents.
    Jiménez-Quevedo P; Sabaté M
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):635-46. PubMed ID: 16076274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex coronary interventions: unprotected left main and bifurcation lesions.
    Barlis P; Tanigawa J; Kaplan S; di Mario C
    J Interv Cardiol; 2006 Dec; 19(6):510-24. PubMed ID: 17107366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Left main coronary artery stenosis].
    Sheiban I; Biondi-Zoccai GG; Moretti C
    G Ital Cardiol (Rome); 2008 Oct; 9(10):684-9. PubMed ID: 18942556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of restenosis after coronary stenting, problem soon resolved].
    Kivelä A; Hartikainen J
    Duodecim; 2005; 121(11):1227-36. PubMed ID: 15999982
    [No Abstract]   [Full Text] [Related]  

  • 10. Still a future for the bare metal stent?
    Barlis P; Di Mario C
    Int J Cardiol; 2007 Sep; 121(1):1-3. PubMed ID: 17360051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
    Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE
    Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent very late stent thrombosis after bare-metal stent implantation.
    Saito T; Asajima H
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):51-3. PubMed ID: 17295327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent thrombosis after percutaneous coronary intervention for bifurcation lesions.
    Tan HC
    J Interv Cardiol; 2009 Apr; 22(2):114-6. PubMed ID: 19379468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
    Harjai KJ; Orshaw P; Boura J; Sporn D
    Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
    Aoki J; Kirtane AJ; Dangas GD; Lansky AJ; Morales A; Kimura M; Kim YH; Moussa I; Weisz G; Kreps EM; Collins M; Frankin-Bond T; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2008 Jan; 101(1):58-62. PubMed ID: 18157966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent era: will we improve 5-year outcomes?
    Cutlip DE
    Coron Artery Dis; 2006 Dec; 17(8):681-4. PubMed ID: 17119376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.